Autonomous system
AS3902 GLAXOSMITHKLINE
Unclassified ARIN
Summary
GlaxoSmithKline (GSK)
enterprise legacy
Corporate network of GlaxoSmithKline (GLAXOSMITHKLINE), the global
pharmaceutical company, registered through ARIN at its US offices in
Philadelphia, Pennsylvania.
What it's used for
- Enterprise networking for GSK's own sites — offices, research facilities, and internal systems.
- About 1,000 IPv4 addresses, an enterprise-sized footprint rather than a provider one.
Notable
- This is a corporate network: traffic from this range is a pharmaceutical company's employees and infrastructure, not consumers.
- The ASN was registered with ARIN in 1994, under a name that only came into existence in 2000 when Glaxo Wellcome merged with SmithKline Beecham — the registry record was clearly renamed as the corporate identity changed beneath it.
This description is AI-generated, best-effort context — not authoritative, and provided without any guarantee of accuracy. Source, and how to suggest an edit.
Address space
Summary
| Country | Name | Prefixes |
|---|---|---|
| US | United States of America | 4 |
Registry
Allocation record
- Registry
- ARIN
- Handle
AS3902- Registry name
- GLAXOSMITHKLINE
- Registrant
- GlaxoSmithKline
- Abuse contact
- csir@gsk.com
- Registered
- 1994-10-04
- Last changed
- 2007-06-08
- Status
- active
Reputation
Classification and threat
Unclassified Not in the curated lists. Most of the ~80,000 allocated ASNs are not.
No IC3 indicators Nothing from the FBI IC3 feed.
Threat data is alpha. Absence of an indicator is not evidence of good behaviour, only of absence from this one feed.
Elsewhere